BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/10/2022 2:28:55 PM | Browse: 650 | Download: 1628
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 69357
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Predictive value of serum alpha-fetoprotein for tumor regression after preoperative chemotherapy for rectal cancer
Manuscript Source Unsolicited Manuscript
All Author List Da-Kui Zhang, Jun Qiao, Shao-Xuan Chen, Zhi-Yong Hou and Jian-Zheng Jie
Funding Agency and Grant Number
Funding Agency Grant Number
Youth Foundation of China–Japan Friendship Hospital 2019-1-QN-42
Corresponding Author Jian-Zheng Jie, MD, Doctor, Doctor, Department of General Surgery, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Beijing 100029, China. dakuizhang2021@126.com
Key Words Rectal cancer; Preoperative chemotherapy; Alpha-fetoprotein; Predictive value; Tumor
Core Tip We analyzed 125 patients with locally advanced rectal cancer retrospectively. The patients received 6 cycles of preoperative chemotherapy (mFOLFOX6 every 2 wk). Serum α-fetoprotein (AFP) of 26 patients rose slightly and returned to normal in two months. These patients achieved better tumor regression grade (TRG0-1) than those with normal AFP (61.5% vs 39.4%). Patients with a slight increase of serum AFP showed better tumor regression during preoperative chemotherapy, and were more likely to achieve pathological complete response (30.8% vs 12.1%).
Publish Date 2022-02-10 14:26
Citation Zhang DK, Qiao J, Chen SX, Hou ZY, Jie JZ. Predictive value of serum alpha-fetoprotein for tumor regression after preoperative chemotherapy for rectal cancer. World J Gastrointest Oncol 2022; 14(2): 525-532
URL https://www.wjgnet.com/1948-5204/full/v14/i2/525.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i2.525
Full Article (PDF) WJGO-14-525.pdf
Full Article (Word) WJGO-14-525.docx